#1 Clinical Trials Search in Europe

Cefuroxime Axetil

This article examines the use of Cefuroxime Axetil, an antibiotic medication, in various clinical trials. These studies aim to evaluate its effectiveness and safety in treating different infections, compare it to other antibiotics, and assess appropriate dosing strategies. The trials cover conditions like pyelonephritis in pregnancy, erythema migrans, and surgical prophylaxis, providing valuable insights into the drug’s applications and potential benefits.

Table of Contents

What is Cefuroxime Axetil?

Cefuroxime Axetil is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called cephalosporins, which are similar to penicillin antibiotics. Cefuroxime Axetil works by stopping the growth of bacteria[1].

Uses and Effectiveness

Cefuroxime Axetil is used to treat a wide range of bacterial infections, including:

  • Urinary tract infections, including those that occur during pregnancy[2]
  • Skin infections
  • Respiratory tract infections, such as pneumonia
  • Lyme disease, particularly the early stage known as erythema migrans[3]
  • Gonorrhea, an uncomplicated form of this sexually transmitted infection

Research has shown that Cefuroxime Axetil is effective in treating these conditions. For example, in a study comparing Cefuroxime Axetil with another antibiotic (doxycycline) for treating erythema migrans (the characteristic rash of early Lyme disease), both antibiotics were found to be similarly effective[4].

Dosage and Administration

Cefuroxime Axetil is available in tablet form and as a dispersible tablet that can be mixed with water. The dosage varies depending on the type and severity of the infection being treated[1]:

  • For adults, the typical dose ranges from 250mg to 500mg, taken twice daily
  • For children, the dose is usually based on body weight
  • For uncomplicated gonorrhea, a single dose of 1000mg may be recommended

It’s important to take Cefuroxime Axetil exactly as prescribed by your healthcare provider. The course of treatment usually lasts 5 to 10 days, but may be longer for some infections.

Special Considerations

There are some special considerations to keep in mind when taking Cefuroxime Axetil:

  • Pregnancy: Cefuroxime Axetil is considered safe for use during pregnancy. In fact, it’s being studied for treating urinary tract infections in pregnant women[2].
  • Breastfeeding: Small amounts of the drug may pass into breast milk. Consult your doctor if you’re breastfeeding.
  • Obesity: For obese patients, dosage adjustments may be necessary. A study is investigating the appropriate dosage of Cefuroxime based on Body Mass Index (BMI)[5].

Side Effects and Safety

Like all medications, Cefuroxime Axetil can cause side effects, although not everyone experiences them. Common side effects may include:

  • Diarrhea
  • Nausea
  • Stomach pain
  • Headache

Serious allergic reactions are rare but possible. Seek immediate medical attention if you experience symptoms of an allergic reaction such as rash, itching, swelling, severe dizziness, or difficulty breathing.

Ongoing Research

Several clinical trials are currently underway to further investigate the use of Cefuroxime Axetil:

  • A study comparing oral versus intravenous Cefuroxime for treating pyelonephritis (a type of kidney infection) in pregnant women[2].
  • Research on the appropriate dosage of Cefuroxime for obese patients undergoing surgery[5].
  • A large-scale study in China evaluating the safety and efficacy of Cefuroxime Axetil dispersible tablets in real-world settings[1].

These ongoing studies aim to improve our understanding of how to use Cefuroxime Axetil most effectively and safely in different patient populations.

Aspect Details
Main Conditions Studied Pyelonephritis in pregnancy, Erythema migrans (Lyme disease), Surgical prophylaxis
Forms of Cefuroxime Axetil Oral tablets, Intravenous injection, Continuous infusion
Comparison Antibiotics Doxycycline (for erythema migrans)
Dosage Considerations Based on BMI, Renal function, Continuous vs. bolus dosing
Key Outcome Measures Clinical improvement, Negative urine cultures, Surgical site infection rates, Drug levels in blood and tissue
Special Populations Pregnant women, Obese patients
Safety Monitoring Adverse reactions, Side effects

FAQ

  • What is Cefuroxime Axetil used for in clinical trials? Cefuroxime Axetil is being studied for various conditions including pyelonephritis in pregnancy, erythema migrans (a symptom of Lyme disease), and as a preventive antibiotic before surgery. It's being tested in both oral and intravenous forms.
  • How does Cefuroxime Axetil compare to other antibiotics in trials? In some trials, Cefuroxime Axetil is being compared to other antibiotics like doxycycline for treating erythema migrans. The goal is to assess if it's as effective or potentially better than existing treatments.
  • Are there any special considerations for using Cefuroxime Axetil in pregnant women? Yes, one trial is specifically looking at using Cefuroxime Axetil to treat pyelonephritis (a kidney infection) in pregnant women. The study compares oral and intravenous forms to find the most effective and safe option for this group.
  • How is the dosage of Cefuroxime Axetil determined in clinical trials? Dosage can vary based on the condition being treated and patient characteristics. For example, one study is adjusting the dose based on the patient's Body Mass Index (BMI) for surgical prophylaxis. Another trial is exploring continuous infusion versus standard bolus dosing.
  • What are researchers measuring to determine if Cefuroxime Axetil is effective? Researchers are looking at various outcomes including clinical improvement (like reduction in symptoms), negative urine cultures, rates of surgical site infections, and levels of the drug in blood and tissue. They're also monitoring for any side effects or adverse reactions.

Ongoing Clinical Trials on Cefuroxime Axetil

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    1 1 1
    Investigated drugs:
    Norway Sweden

  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium The Netherlands

  • Study on Reducing Infections After Bladder Removal Surgery Using Pivmecillinam Hydrochloride and Other Antibiotics for Patients Undergoing Ureteral Stent Removal

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Pyelonephritis: A type of urinary tract infection that affects one or both kidneys. It can be serious, especially during pregnancy.
  • Erythema Migrans: A red, expanding rash often seen in the early stage of Lyme disease. It's sometimes described as a 'bull's-eye' rash.
  • Antibiotic Prophylaxis: The use of antibiotics before surgery or a medical procedure to prevent infection.
  • Body Mass Index (BMI): A measure that uses your height and weight to work out if your weight is healthy. It's used in some studies to determine appropriate drug dosages.
  • Intravenous (IV): A way of giving medication directly into a vein using a needle or tube.
  • Oral Administration: Taking medication by mouth, usually in the form of pills, tablets, or liquid.
  • Clinical Trial: A type of research study that tests how well new medical approaches work in people.
  • Placebo: A substance that has no active ingredients but is made to look like real medicine. It's used in some studies to compare with the actual drug being tested.
  • Randomized Trial: A study where participants are randomly assigned to different treatment groups.
  • Surgical Site Infection: An infection that occurs after surgery in the part of the body where the surgery took place.

References

  1. https://clinicaltrials.gov/study/NCT03020940
  2. https://clinicaltrials.gov/study/NCT06527560
  3. https://clinicaltrials.gov/study/NCT01518192
  4. https://clinicaltrials.gov/study/NCT03584919
  5. https://clinicaltrials.gov/study/NCT03141476